Thomas Gaspar

Thomas Gaspar

Auto-generated profile, based on publicly available information

Thomas Gaspar

Department of Electrophysiology , Heart Center , University Leipzig , Strümpellstr. 39, 04289, Leipzig , Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2012 in EP Europace
Verified
Journal Article
Open access
PDF file
PSPhilipp Sommer
Philipp Sommer
AWAgnieszka Wojdyla-Hordynska
Agnieszka Wojdyla-Hordynska
SRSascha Rolf
Sascha Rolf
TGThomas Gaspar
Thomas Gaspar
CECharlotte Eitel
Charlotte Eitel
CPChristopher Piorkowski
Christopher Piorkowski
Three-dimensional (3D) mapping has been established for clinical routine in an interventional electrophysiology (EP). Recently, a novel sensor-based 3D catheter tracking system has been introduced integrating 3D non-fluoroscopic catheter navigation into the environment of pre-recorded 2D fluoroscopy [MediGuide™ Technology (MG)]. We are reporting on the first clinical experience for ablation of typical atrial flutter. First we aimed to demonstrate safety and feasibility of this new technique. Secondly, procedural aspects such as effectiveness, procedure, and fluoroscopy time should be evaluated. Ten consecutive patients (100% male, age 68 ± 8 years) were ablated using MG technology. Two steerable diagnostic EP catheters (MediGuide Enabled Livewire™ Catheter, SJM) were used for coronary sinus cannulation and anatomical cavo-tricuspidal isthmus (CTI) reconstruction within the EnSite NavX™ System (NavX). Ablation was performed with a conventional 8 mm tip ablation catheter (IBI, SJM). In all 10 patients both sensor-equipped MG catheters could be tracked non-fluoroscopically. Successful anatomical CTI reconstruction was performed and complete isthmus block was documented after the ablation. Total procedure duration was comparable with conventional procedures (55 ± 8 min). Usage of the MG tracking system resulted in a fluoroscopy time of 2.5 ± 2 min. No adverse events occurred during the procedures. For the first clinical application of the MG technology in an interventional electrophysiology we found a stable system enabling excellent 3D orientation for spatial catheter positioning on the basis of underlying pre-recorded cine loops. Clinically, the MG technology allowed successful procedures with short fluoroscopy times, even though a sensor-equipped ablation catheter was not yet available for use in the study.

21 February 2011 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
AAArash Arya
Arash Arya
YHYan Huo
Yan Huo
FFFredrick Frogner
Fredrick Frogner
UWUlrike Wetzel
Ulrike Wetzel
PSPhilipp Sommer
Philipp Sommer
GHGerhard Hindricks
Gerhard Hindricks

1 January 2009 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
GHGerhard Hindricks
Gerhard Hindricks
USUniv.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
Univ.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
PSPhilipp Sommer
Philipp Sommer
TGThomas Gaspar
Thomas Gaspar
KBKerstin Bode
Kerstin Bode
NDNikolaos Dagres
Nikolaos Dagres
Catheter ablation provides curative treatment for atrial fibrillation (AF). Data on anticoagulation after the procedure are sparse. We investigated real-life antithrombotic treatment after AF ablation and examined its adherence to current recommendations. Eight hundred forty-four patients (age 58 ±10 years) underwent AF ablation. Most patients had a CHADS2 score of 0 (46%) or 1 (45%). Seven-day Holter was performed at three, six and 12 months after ablation. Decision on anticoagulation treatment was made by general practitioners and referring cardiologists in consultation with the patients. At discharge, anticoagulants were prescribed for the vast majority (94–96%) of patients. This percentage remained high at three and six months (80–90%) without differences between stroke risk groups. At 12 months, the use of anticoagulants was mainly influenced by the detection of recurrence; usage exceeded 90% in all stroke risk groups in patients with recurrences. In patients without recurrences, differences between risk groups were significant but small, ranging from 42% (CHADS2=0) to 62% (CHADS2≥2) (p=0.033). In multivariate analysis, the only factor independently associated with oral anticoagulation at 12 months was the detection of recurrences (odds ratio=16.2, p<0.001), whereas the effect of the CHADS2 score was not significant (p=0.080).The effect of all other examined factors was also not significant. Contrary to current recommendations, anticoagulation after AF ablation is hardly guided by the stroke risk profile and remains high even in low-risk patients. The most important factor influencing the use of anticoagulants is the detection of recurrences during follow-up. This results in possible overtreatment of low-risk patients.

24 February 2012 in EP Europace
Verified
Journal Article
Open access
PDF file
TGThomas Gaspar
Thomas Gaspar
SKSimon Kircher
Simon Kircher
CPChristopher Piorkowski
Christopher Piorkowski
This editorial refers to ‘Impact of pulmonary vein anatomy assessed by cardiac magnetic resonance imaging on endoscopic pulmonary vein isolation in consecutive patients’ by A. Metzneret al., on page 474

1 March 2013 in JACC
Verified
Journal Article
Closed access
ABAndreas Bollmann
Andreas Bollmann
JKJedrzej Kosiuk
Jedrzej Kosiuk
JKJelena Kornej
Jelena Kornej
KMKrzysztof Myrda
Krzysztof Myrda
AAArash Arya
Arash Arya
GLGregory Lip
Gregory Lip

20 June 2012 in EP Europace
Verified
Journal Article
Open access
PDF file
TGThomas Gaspar
Thomas Gaspar
GHGerhard Hindricks
Gerhard Hindricks
CPChristopher Piorkowski
Christopher Piorkowski
This editorial refers to ‘Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap’ by M.A. Miller et al., on page 653